Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Cryptic axonal antigens and axonal loss in multiple sclerosis.

George H DeVries¹

¹Research 151, Hines VA Hospital, Hines, Illinois 60141, USA. George.DeVries@med.va.gov

Neurochemical Research

|January 25, 2005

Summary

Antibodies targeting nerve cell membranes (axolemma-enriched fractions) may cause axonal loss in Multiple Sclerosis (MS). These antibodies are elevated in MS patients, suggesting a role in disease pathology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.

Glia·2016

Same author

Platelet-derived growth factor-BB activates calcium/calmodulin-dependent and -independent mechanisms that mediate Akt phosphorylation in the neurofibromin-deficient human Schwann cell line ST88-14.

The Journal of biological chemistry·2013

Same author

Analysis of humoral immune responses to LM1 ganglioside in guinea pigs.

Journal of neuroimmunology·2012

Same author

Oligodendrocyte progenitor cells proliferate and survive in an immature state following treatment with an axolemma-enriched fraction.

ASN neuro·2011

Same author

Differential localization of neuregulin-1 type III in the central and peripheral nervous system.

Brain research·2010

Same author

A career perspective on the discipline of neurochemistry.

Neurochemical research·2008

Area of Science:

Neuroimmunology
Neuropathology

Background:

Axonal loss is a key factor in Multiple Sclerosis (MS) functional deficits.
The molecular mechanisms driving axonal loss in MS remain unclear.

Purpose of the Study:

To review evidence suggesting antibodies against axolemma-enriched fractions (AEF) contribute to axonal destruction in MS.
To explore the potential identity and role of these cryptic antigens in MS pathology.

Main Methods:

Review of existing literature on antibodies to AEF and their effects.
Analysis of AEF composition and immune accessibility.
Comparison of AEF antibody levels in MS patients versus other neurological diseases.

Main Results:

AEF contains potent antigens that induce neurite destruction and inhibit outgrowth in vitro.
Antibodies to AEF are found at higher levels in the cerebrospinal fluid and sera of MS patients.
Myelin's paranodal loops may shield these antigens from immune surveillance in vivo.

Conclusions:

Antibodies to cryptic AEF antigens are implicated in the axonal destruction observed in Multiple Sclerosis.
Further research is needed to identify these antigens and confirm their pathogenic role in MS.

Related Experiment Videos